Recipharm Overview

  • Founded
  • 1995
Founded
  • Status
  • Public
  • Employees
  • 7,383
Employees
  • Stock Symbol
  • RECI B
Stock Symbol
  • Investments
  • 30
  • Share Price
  • $27.35
  • (As of Friday Closing)

Recipharm General Information

Description

Recipharm AB is a global biotechnology company that develops pharmaceutical drugs and technologies. The company operates in two core areas that include development and technology, and manufacturing. Recipharm's largest business stream is its manufacturing operation, which focuses on delivering a large number of pharmaceuticals in a variety of dosage forms. This segment also provides packaging services for customers. The company's overall business model focuses on uniting licensed development and manufacturing companies.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
STO
Primary Office
  • Box 603
  • 101 32 Stockholm
  • Sweden
+46 0000000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Recipharm Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$27.35 $27.53 $7.10 - $28.27 $2.76B 101M 699K $0.23

Recipharm Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 2,760,776 1,475,385 1,207,578 1,191,070
Revenue 1,076,385 783,685 727,993 619,219
EBITDA 177,231 134,463 112,102 60,374
Net Income 21,673 36,278 18,317 (19,949)
Total Assets 2,509,288 1,471,918 1,414,645 1,432,941
Total Debt 1,175,659 556,952 497,499 511,527
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Recipharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Recipharm‘s full profile, request access.

Request a free trial

Recipharm Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Recipharm AB is a global biotechnology company that develops pharmaceutical drugs and technologies. The company operates
Pharmaceuticals
Stockholm, Sweden
7,383 As of 2020
00000
00000000 00000

000000 0

i ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse
000000000000000
Montreal, Canada
000 As of 0000

000 0000

r incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ul
000000000000000
Riverview, MI
00 As of 0000
000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Recipharm Competitors (29)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ropack Pharma Solutions Corporation Montreal, Canada 000
000 0000000 Corporate Backed or Acquired Riverview, MI 00 000000&0
000000 000000 Corporation Ravensburg, Germany 0000
0000000000 000000 Corporation Ennigerloh, Germany
00. 00000'0 000000 Corporation Hyderabad, India 00000 00000 00000000000 00000
You’re viewing 5 of 29 competitors. Get the full list »

Recipharm Executive Team (10)

Name Title Board Seat Contact Info
Thomas Eldered President & Chief Executive Officer
Tobias Hägglöv Chief Financial Officer
Kjell Johansson Executive Vice President & Chief Operating Officer
Anke Mollowitz Key Account Director
Mark Quick Executive Vice President, Corporate Development
You’re viewing 5 of 10 executive team members. Get the full list »

Recipharm Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Recipharm Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Recipharm‘s full profile, request access.

Request a free trial

Recipharm Investments & Acquisitions (30)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 01-Feb-2021 00000 0000000 000.00 Other Healthcare Technology Systems 000000 0000000
0000000 0000000 06-Mar-2020 000000000000000000 00000 Drug Delivery 000000 0000000
0000000 000000 05-Mar-2020 00000 00000 00 000.00 Biotechnology
0000000 000000 24-Apr-2019 00000 00000 00 00.000 Biotechnology 0000-00000 0000 00.0
Sanofi (Inhalation contract manufacturing business) 01-Oct-2018 Merger/Acquisition 000.00 Pharmaceuticals 000000 0000000
You’re viewing 5 of 30 investments and acquisitions. Get the full list »

Recipharm Subsidiaries (2)

Company Name Industry Location Founded
OnTarget Chemistry Other Commercial Services Uppsala, Sweden 2008
00000 000000000000 Pharmaceuticals Karnal, India 0000
To view Recipharm’s complete subsidiaries history, request access »

Recipharm Exits (4)

Company Name Exit Date Exit Type Exit Size Status Buyers
000000 000000 02-Oct-2015 00000 00000 00 00.000 Completed
  • 2 buyers
000000 000000 29-Sep-2015 0000000000 Completed
  • 2 buyers
00000 000000000 01-Jan-2009 000000000000000000 Completed
  • 000000000
Inventiva Pharma 30-Oct-2008 Merger/Acquisition Completed
To view Recipharm’s complete exits history, request access »